-
Loading metrics
Open Access
Peer-reviewed
Research Article
Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes.
-
Nan Lu ,
Contributed equally to this work with: Nan Lu, Hanxiao Sun
Current Address: Department of Endocrine and Metabolic Diseases, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
Hanxiao Sun ,
Contributed equally to this work with: Nan Lu, Hanxiao Sun
Current Address: Department of Laboratory Medicine, Shanghai Tongren Hospital, Shanghai Jiaotong University School of Medicine, 200336, Shanghai, China
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
JingJia Yu,
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
Xiaojing Wang,
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
Dongmei Liu,
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
Lin Zhao,
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
Lihao Sun,
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
Hongyan Zhao,
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
Bei Tao ,
* E-mail: catherine-tao@163.com (BT); liujianmin@medmail.com.cn (JML)
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯ -
Jianmin Liu
* E-mail: catherine-tao@163.com (BT); liujianmin@medmail.com.cn (JML)
Affiliation Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai Institute of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai 200025, China
⨯
Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes.
- Nan Lu,
- Hanxiao Sun,
- JingJia Yu,
- Xiaojing Wang,
- Dongmei Liu,
- Lin Zhao,
- Lihao Sun,
- Hongyan Zhao,
- Bei Tao,
- Jianmin Liu
- Published: July 15, 2015
- https://doi.org/10.1371/journal.pone.0132744